HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Marc Herbert Selected Research

7- fluoro- 2- oxo- 4- (2- (4- (thieno(3,2- c)pyridin- 4- yl)piperazin- 1- yl)ethyl)- 1,2- dihydroquinoline- 1- acetamide

8/2004Serotonin aggravates exercise-induced cardiac ischemia in the dog: effect of serotonin receptor antagonists.
11/2002Serotonin receptor blockade improves distal perfusion after lower limb ischemia in the fatty Zucker rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Marc Herbert Research Topics

Disease

12Thrombosis (Thrombus)
04/2016 - 01/2003
7Neoplasms (Cancer)
02/2015 - 09/2003
5Ischemia
08/2004 - 11/2002
4Infarction (Infarctions)
08/2005 - 09/2002
4Myocardial Infarction
04/2005 - 02/2003
3Hypoxia (Hypoxemia)
02/2015 - 02/2005
3Inflammation (Inflammations)
04/2008 - 09/2003
3Ischemic Stroke
05/2007 - 05/2004
2Hemorrhage
12/2013 - 01/2002
2Arthritis (Polyarthritis)
04/2013 - 08/2002
2Heart Diseases (Heart Disease)
01/2013 - 01/2005
2Radiation Injuries (Radiation Sickness)
01/2013 - 01/2002
2Cardiovascular Diseases (Cardiovascular Disease)
09/2009 - 09/2002
2Pathologic Neovascularization
04/2009 - 07/2002
2Peripheral Arterial Disease
05/2007 - 04/2005
2Fibrosis (Cirrhosis)
01/2005 - 01/2002
2Necrosis
08/2004 - 08/2002
2Atherosclerosis
05/2004 - 08/2002
2Reperfusion Injury
09/2003 - 02/2003
2Venous Thrombosis (Deep-Vein Thrombosis)
01/2003 - 08/2002
2Myocardial Ischemia (Ischemic Heart Diseases)
09/2002 - 03/2002
2Venous Thromboembolism
08/2002 - 01/2002
1Wounds and Injuries (Trauma)
01/2016
1Nervous System Diseases (Neurological Disorders)
01/2016
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2016
1Graft vs Host Disease (Graft-Versus-Host Disease)
04/2010
1Retinal Neovascularization
04/2009
1Vasculitis (Vasculitides)
04/2008
1Acute Disease
05/2007
1Diabetic Nephropathies (Diabetic Nephropathy)
03/2006
1Glioblastoma (Glioblastoma Multiforme)
08/2005
1Unstable Angina
04/2005
1Atrial Fibrillation
02/2005
1Hypertrophy
01/2005
1Heart Failure
01/2005
1Thrombocytopenia (Thrombopenia)
01/2005
1Hypertension (High Blood Pressure)
08/2004
1Tachycardia (Tachyarrhythmias)
08/2004

Drug/Important Bio-Agent (IBA)

6Clopidogrel (Plavix)FDA Link
05/2007 - 01/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2005 - 07/2002
3ThrombinFDA Link
04/2016 - 01/2003
3IrbesartanFDA LinkGeneric
03/2006 - 06/2004
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2005 - 05/2003
3Heparin (Liquaemin)FDA LinkGeneric
01/2005 - 11/2003
3Fondaparinux (Arixtra)FDA Link
01/2005 - 01/2002
3AntithrombinsIBA
11/2004 - 01/2003
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2015 - 09/2003
2Biomarkers (Surrogate Marker)IBA
01/2015 - 01/2003
2AntibodiesIBA
04/2013 - 01/2005
2Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2013 - 01/2002
2Transcription Factors (Transcription Factor)IBA
08/2005 - 02/2005
2Purinergic P2Y Receptor AntagonistsIBA
04/2005 - 05/2004
2Neuropilin-1IBA
02/2005 - 09/2004
2celivaroneIBA
02/2005 - 08/2004
2Pharmaceutical PreparationsIBA
01/2005 - 08/2002
2Plasminogen Activators (Plasminogen Activator)IBA
01/2005 - 03/2002
2Serotonin (5 Hydroxytryptamine)IBA
08/2004 - 11/2002
2acetamideIBA
08/2004 - 09/2003
27- fluoro- 2- oxo- 4- (2- (4- (thieno(3,2- c)pyridin- 4- yl)piperazin- 1- yl)ethyl)- 1,2- dihydroquinoline- 1- acetamideIBA
08/2004 - 11/2002
2GABA-A Receptors (GABA(A) Receptor)IBA
08/2004 - 09/2003
2SSR180575IBA
08/2004 - 09/2003
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2003 - 08/2002
2Enoxaparin (Lovenox)FDA LinkGeneric
08/2002 - 01/2002
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2016
1EVT901IBA
01/2016
1Indicators and Reagents (Reagents)IBA
01/2016
1Proteins (Proteins, Gene)FDA Link
02/2015
1Oxygen (Dioxygen)IBA
02/2015
1SSR128129EIBA
01/2015
1erucylphosphocholineIBA
01/2015
1RivaroxabanIBA
12/2013
1DabigatranFDA Link
12/2013
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2013
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
04/2013
1Transforming Growth Factor beta (TGF-beta)IBA
01/2013
1xaliprodenIBA
01/2013
1rho-Associated KinasesIBA
09/2009
1Vascular Endothelial Growth Factor BIBA
04/2009
1Type 1 Angiotensin ReceptorIBA
03/2006
1Small Interfering RNA (siRNA)IBA
08/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2005
1Ticlopidine (Ticlid)FDA LinkGeneric
04/2005
1ElementsIBA
02/2005
1IntegrinsIBA
02/2005
1Platelet Factor 4IBA
01/2005
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2005
1Matrix Metalloproteinases (MMPs)IBA
01/2005
1Peptide Hydrolases (Proteases)FDA Link
11/2004
1Serotonin AntagonistsIBA
08/2004
1pyridineIBA
08/2004
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
08/2004
1KetanserinIBA
08/2004
1Adrenergic Agents (Adrenergic Drugs)IBA
08/2004
1Isoproterenol (Isoprenaline)FDA LinkGeneric
08/2004

Therapy/Procedure

5Therapeutics
04/2005 - 01/2002
1Subcutaneous Injections
01/2015
1Radiotherapy
01/2013
1Homologous Transplantation
04/2010
1Heart Transplantation (Grafting, Heart)
04/2008
1Percutaneous Coronary Intervention
05/2007